Ironwood Pharmaceuticals
IRWD
IRWD
202 hedge funds and large institutions have $1.84B invested in Ironwood Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.8B → $1.84B (+$36.1M)
1.12% less ownership
Funds ownership: 112.88% → 111.76% (-1.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
202
Holding in Top 10
2
Calls
$13.8M
Puts
$7.15M
Top Buyers
| 1 | +$67.1M | |
| 2 | +$24.6M | |
| 3 | +$15.6M | |
| 4 |
SPC
Slate Path Capital
New York
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$11.6M |
Top Sellers
| 1 | -$57.1M | |
| 2 | -$44.3M | |
| 3 | -$39.6M | |
| 4 |
MP
MFN Partners
Boston,
Massachusetts
|
-$34M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$14.6M |